Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Essity AB ( ($SE:ESSITY.B) ) is now available.
Essity has secured a seven-year EUR 400 million loan from the European Investment Bank on favorable terms to finance research, development and innovation across all its business areas. The funding is aimed at strengthening Essity’s innovation capabilities, supporting value-enhancing upgrades and breakthrough product launches that combine sustainability and performance, reinforcing the company’s competitive position while contributing to Europe’s technological leadership in hygiene and health and advancing the green transition and circular economy objectives.
The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK270.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.
More about Essity AB
Essity is a global leading hygiene and health company whose products, solutions and services are used daily by around one billion people worldwide. It operates in roughly 150 countries with a portfolio of well-known brands including TENA, Tork, Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa, generating about SEK 138 billion (EUR 13 billion) in net sales in 2025 and employing 36,000 people, with headquarters in Stockholm and a listing on Nasdaq Stockholm.
Average Trading Volume: 1,362,558
Technical Sentiment Signal: Hold
Current Market Cap: SEK176.6B
See more insights into ESSITY.B stock on TipRanks’ Stock Analysis page.